BioNTech SE posted a quarterly loss that was wider than analysts foresaw amid low demand for Covid-19 vaccines and increased spending on developing new products.
Source link
lol
BioNTech SE posted a quarterly loss that was wider than analysts foresaw amid low demand for Covid-19 vaccines and increased spending on developing new products.
Source link
lol